PubMed Health⌕ Search

Biomedical subjects

Marek Langner

Publications and source records attributed to Marek Langner.

20 records · Page 2Linked to original sources

The effect of selected anions on dipalmitoylphosphatidylcholine phase transitions.

The effect of three anions, Cl-, Br- and I-, on the phase transitions of dipalxnitoylphosphatidyicholine (DPPC) was measured. Main phase transition was modestly affected by these anions in the salt concentration range 0.2 M. For Cl- and Br- the temperature of main phase transition was lower (by about 0.5 degrees C), its half-width modestly larger and enthalpy practically unchanged, all three parameters were altered to a much larger deuce. Main phase transition temperature was 1.5 degrees C lower and the peak hall-width significantly smaller. These changes were not accompanied by any alteration in main phase transition enthalpy. Iodide shifted the pretransition temperature toward lower values and increased its half-width to such an extent that at concentrations above 100 mM it was practically undetectable. Besides cations, the presence of anions also has a distinct effect on lipid bilayer interface properties.

1,2-Dipalmitoylphosphatidylcholine↗

Pharmacokinetics of liposomes designed to carry glucocorticoids.

Over the past decade, particulate drug formulations have been successfully employed to reduce undesired side effects and improve drug biodistribution. Despite numerous experimental data, there are relatively few theoretical studies regarding the pharmacokinetics of such formulations. A quantitative pharmacokinetic description of particulate drug forms requires serious adjustments in existing theoretical approaches, due to formulation size. Thus, blood vessel permeabilization and the immunological system need to be accounted for. In this paper, we present a pharmacokinetic model intended to describe the distribution of glucocorticoid (prednisolone phosphate) encapsulated in long-circulated liposomes and its qualitative analysis. In order to achieve qualitative and quantitative agreement with experimental patterns of time-dependent liposome concentration changes in blood, liver and spleen, the existence of two hypothetical liposome populations was assumed. The two populations differ in their accumulation capacities, dosage and time constants. The first population is accumulated in the liver with a time constant of 50 s(-1) and a saturation level of 0.005 micromol/animal, whereas the second with 0.003 s(-1) and 50 micromol/animal, respectively. Such liposome parameterization results from the theoretical model used, however, it may have a physiological foundation. If the two opsonin and/or macrophage types that interact with the liposomes are assumed to have different characteristics, then the pharmacokinetic data obtained experimentally in an animal model can be described correctly.

1,2-Dipalmitoylphosphatidylcholine↗